These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

582 related items for PubMed ID: 16942942

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)].
    Nadar SK, Blann A, Beevers DG, Lip GY.
    J Intern Med; 2005 Oct; 258(4):336-43. PubMed ID: 16164572
    [Abstract] [Full Text] [Related]

  • 4. In vivo platelet activation is responsible for enhanced vascular endothelial growth factor levels in hypertensive patients.
    Ferroni P, Martini F, D'Alessandro R, Magnapera A, Raparelli V, Scarno A, Davì G, Basili S, Guadagni F.
    Clin Chim Acta; 2008 Feb; 388(1-2):33-7. PubMed ID: 18001701
    [Abstract] [Full Text] [Related]

  • 5. Platelet morphology and plasma indices of platelet activation in essential hypertension: effects of amlodipine-based antihypertensive therapy.
    Nadar S, Blann AD, Lip GY.
    Ann Med; 2004 Feb; 36(7):552-7. PubMed ID: 15513305
    [Abstract] [Full Text] [Related]

  • 6. Plasma markers of angiogenesis in pregnancy induced hypertension.
    Nadar SK, Karalis I, Al Yemeni E, Blann AD, Lip GY.
    Thromb Haemost; 2005 Nov; 94(5):1071-6. PubMed ID: 16363251
    [Abstract] [Full Text] [Related]

  • 7. Significant decrease in angiopoietin-1 and angiopoietin-2 after radical prostatectomy in prostate cancer patients.
    Caine GJ, Ryan P, Lip GY, Blann AD.
    Cancer Lett; 2007 Jun 28; 251(2):296-301. PubMed ID: 17240049
    [Abstract] [Full Text] [Related]

  • 8. Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromes.
    Lee KW, Lip GY, Blann AD.
    Circulation; 2004 Oct 19; 110(16):2355-60. PubMed ID: 15302795
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Tamoxifen and aromatase inhibitors differentially affect vascular endothelial growth factor and endostatin levels in women with breast cancer.
    Holmes CE, Huang JC, Pace TR, Howard AB, Muss HB.
    Clin Cancer Res; 2008 May 15; 14(10):3070-6. PubMed ID: 18483373
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Plasma angiopoietin-1, angiopoietin-2, and angiopoietin receptor tie-2 levels in congestive heart failure.
    Chong AY, Caine GJ, Freestone B, Blann AD, Lip GY.
    J Am Coll Cardiol; 2004 Feb 04; 43(3):423-8. PubMed ID: 15013125
    [Abstract] [Full Text] [Related]

  • 13. Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade.
    Lip PL, Chatterjee S, Caine GJ, Hope-Ross M, Gibson J, Blann AD, Lip GY.
    Br J Ophthalmol; 2004 Dec 04; 88(12):1543-6. PubMed ID: 15548809
    [Abstract] [Full Text] [Related]

  • 14. Platelet indexes in relation to target organ damage in high-risk hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
    Nadar SK, Blann AD, Kamath S, Beevers DG, Lip GY.
    J Am Coll Cardiol; 2004 Jul 21; 44(2):415-22. PubMed ID: 15261941
    [Abstract] [Full Text] [Related]

  • 15. Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Spencer CG, Martin SC, Felmeden DC, Blann AD, Beevers GD, Lip GY.
    Int J Cardiol; 2004 Apr 21; 94(2-3):293-300. PubMed ID: 15093996
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Soluble P-selectin as a marker of in vivo platelet activation.
    Ferroni P, Martini F, Riondino S, La Farina F, Magnapera A, Ciatti F, Guadagni F.
    Clin Chim Acta; 2009 Jan 21; 399(1-2):88-91. PubMed ID: 18835553
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.